AMAG Pharmaceuticals, Inc

(NASDAQ:AMAG)

Latest On AMAG Pharmaceuticals, Inc (AMAG):

Date/Time Type Description Signal Details
2020-11-25 11:14 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 03:10 ESTEarnings EstimateAn EPS average of $0.11 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-08 07:07 ESTFinancialsCompany financials have been released.Neutral
2020-11-01 16:58 ESTFinancialsCompany financials have been released.Neutral
2020-10-09 08:06 ESTAnalyst RatingThe Analyst Target Price has increased from $11.43 to $11.96.Neutral
2020-10-07 10:35 ESTNewsAmag Pharma mulling options related to Makena withdrawalN/A
2020-10-06 04:04 ESTNewsFDA to yank approval for Amag Pharma's Makena; shares down 6%N/A
2020-10-06 04:02 ESTNewsFDA provides further update on Amag Pharma's Makena approvalN/A
2020-10-05 11:45 ESTInsider TradeCapital Management LP Camber has indirectly disposed of 4,390,000 shares.Sell
2020-10-05 04:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $11.45 to $11.43.Sell
2020-10-03 08:07 ESTAnalyst RatingThe Analyst Target Price has increased from $9.5 to $11.45.Neutral
2020-10-02 13:18 ESTNewsCovis takes out Amag Pharma for $498MN/A
2020-10-01 04:36 ESTNewsAMAG Pharma up 41% on takeover rumorN/A
2020-09-26 04:10 ESTFinancialsCompany financials have been released.Neutral
2020-08-19 04:05 ESTAnalyst RatingThe Analyst Target Price has increased from $9.07 to $9.5.Neutral
2020-08-10 00:05 ESTAnalyst RatingThe Analyst Target Price has increased from $8.93 to $9.07.Neutral
2020-08-09 08:49 ESTNewsAMAG Pharmaceuticals, Inc. (AMAG) CEO Scott Myers on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-08 12:05 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 04:05 ESTEarnings EstimateAn EPS average of $0.02 is estimated for the quarter ending on September 30, 2020.Buy
2020-08-07 04:05 ESTAnalyst RatingThe Analyst Target Price has increased from $8.14 to $8.93.Neutral
2020-08-06 20:06 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 10:15 ESTNewsAMAG Pharmaceuticals EPS beats by $0.10, misses on revenueN/A
2020-07-31 00:07 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 15:47 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:37 ESTNewsPalatin Tech and Amag Pharma ax Vyleesi agreementN/A
2020-07-23 19:29 ESTNewsAMAG Pharma inks licensing deal for ciraparantagN/A
2020-07-23 16:12 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 07:21 ESTNewsAMAG Pharma's finance chief bids adieuN/A
2020-06-04 18:37 ESTInsider TradeDAVEY SCOON has directly acquired 10,269 shares and currently holds 43,898 shares.Buy
2020-06-04 18:37 ESTInsider TradeKathrine O'Brien has directly acquired 10,269 shares and currently holds 18,949 shares.Buy
2020-06-04 18:37 ESTInsider TradePAUL R. FONTEYNE has directly acquired 10,269 shares and currently holds 14,676 shares.Buy
2020-06-04 18:37 ESTInsider TradeJAMES R SULAT has directly acquired 10,269 shares and currently holds 35,090 shares.Buy
2020-06-04 18:37 ESTInsider TradeJohn A. Fallon has directly acquired 10,269 shares and currently holds 37,362 shares.Buy
2020-06-04 18:37 ESTInsider TradeGINO SANTINI has directly acquired 10,269 shares and currently holds 41,473 shares.Buy
2020-06-04 18:37 ESTInsider TradeAnne M. Phillips has directly acquired 10,269 shares and currently holds 18,949 shares.Buy
2020-06-04 18:37 ESTInsider TradeDAVID EDWARD JOHNSON has directly acquired 10,269 shares and currently holds 14,676 shares.Buy
2020-06-02 00:06 ESTAnalyst RatingThe Analyst Target Price has decreased from $8.81 to $8.14.Neutral
2020-05-15 20:04 ESTFinancialsCompany financials have been released.Neutral
2020-05-14 04:08 ESTFinancialsCompany financials have been released.Neutral
2020-05-11 21:54 ESTNewsAMAG Pharmaceuticals EPS misses by $0.23, beats on revenueN/A
2020-05-11 21:52 ESTNewsAMAG Pharmaceuticals, Inc. (AMAG) CEO Scott Myers on Q1 2020 Results - Earnings Call TranscriptN/A
2020-05-11 21:52 ESTNewsAMAG Pharmaceuticals: Shedding Lackadaisical Segments And Management - Becoming A Focused, Undervalued Pure PlayN/A
2020-05-03 08:06 ESTFinancialsCompany financials have been released.Neutral
2020-04-30 04:05 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.19 to $8.81.Neutral
2020-04-29 12:05 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.31 to $9.19.Neutral
2020-04-29 04:11 ESTNewsAMAG Pharma gets its new CEON/A
2020-04-28 08:05 ESTAnalyst RatingThe Analyst Target Price has increased from $9.19 to $9.31.Buy
2020-04-24 04:05 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.31 to $9.19.Neutral
2020-04-17 04:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.44 to $9.31.Neutral
2020-04-11 01:41 ESTNewsAMAG Pharmaceuticals EPS of -$5.89N/A

About AMAG Pharmaceuticals, Inc (AMAG):

AMAG Pharmaceuticals, Inc., a pharmaceutical company, develops, manufactures, and commercializes therapeutics for maternal and women's health, and anemia management in the United States. The company markets Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, as well as patients who have chronic kidney disease; Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Intrarosa(prasterone) vaginal insert steroid for the treatment of dyspareunia due to menopause; and Vyleesi (bremelanotide), an auto-injector device for the treatment of hypoactive sexual desire disorder in pre-menopausal women. Its product candidates also include AMAG-423 (ovine), an antibody fragment, which is in Phase 2b/3a trial for the treatment of severe preeclampsia in pregnant women; and Ciraparantag, an anticoagulant reversal agent that is in planned Phase 2b trial for the treatment of novel oral anticoagulants or low molecular weight heparin. The company sells Feraheme to authorized wholesalers and specialty distributors. The company has license agreements with Endoceutics, Inc., Palatin Technologies, Inc., Velo Bio, LLC, Prasco, LLC, Perosphere Pharmaceuticals Inc., and Antares Pharma, Inc. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts. As of November 12, 2020, AMAG Pharmaceuticals, Inc. operates as a subsidiary of Covis Group S.à r.l.

See Advanced Chart

General

  • Name AMAG Pharmaceuticals, Inc
  • Symbol AMAG
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 440
  • Last Split Factor3:2
  • Last Split Date1991-09-26
  • Fiscal Year EndDecember
  • IPO Date1986-06-12
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.amagpharma.com
View More

Valuation

  • Forward PE 30.58
  • Price/Sales (Trailing 12 Mt.) 1.56
  • Price/Book (Most Recent Quarter) 1.87
  • Enterprise Value Revenue 2.06
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Current Year EPS Estimate -$0.63
  • Next Year EPS Estimate $0.38
  • Next Quarter EPS Estimate $0.05
  • Profit Margin -77%
  • Operating Margin -14%
  • Return on Assets -3%
  • Revenue 300.12 million
  • Earnings Per Share -$6.83
  • Revenue Per Share $8.77
  • Gross Profit 219.35 million
  • Quarterly Earnings Growth 11.1%
View More

Highlights

  • Market Capitalization 477.47 million
  • EBITDA -55406000
  • PEG Ratio 0.32
  • Analyst Target Price $11.96
  • Book Value Per Share $7.42
View More

Share Statistics

  • Shares Outstanding 34.73 million
  • Shares Float 23.47 million
  • % Held by Insiders 229%
  • % Held by Institutions 101.08%
  • Shares Short 6.29 million
  • Shares Short Prior Month 7.23 million
  • Short Ratio 1.83
  • Short % of Float 38%
  • Short % of Shares Outstanding 18%
View More

Technicals

  • Beta 0.87
  • 52 Week High $13.77
  • 52 Week Low $4.41
  • 50 Day Moving Average 13.65
  • 200 Day Moving Average 10.05
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

AMAG Pharmaceuticals, Inc (AMAG) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

AMAG Pharmaceuticals, Inc (AMAG) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

AMAG's next estimated earnings release date is May 11, 2021.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-06$N/A$1.19-$0.0112000%
2020-06-302020-08-06$N/A-$0.23-$0.19-21.05%
2020-03-312020-05-11$68.66 million-$0.30-$0.03-900%
2019-12-312020-03-04$89.71 million-$0.35-$0.350%
2019-09-302019-11-01$84.13 million-$0.42-$0.6636.36%
2019-06-302019-08-07$78.11 million-$0.87-$0.57-52.63%
2019-03-312019-05-07$75.8 million-$0.90-$0.26-246.15%
2018-12-312019-02-07$88.12 million-$0.60-$0.8831.82%
2018-09-302018-11-01$122.24 million-$1.88-$0.79-137.97%
2018-06-302018-08-02$146.25 million-$0.75$0.26-388.46%
2018-03-312018-05-03$146.36 million-$1.59-$0.04-3875%
2017-12-312018-02-27$158.34 million$0.10$0.0911.11%
2017-09-302017-11-02$153.74 million-$4.31$0.52-928.85%
2017-06-302017-08-03$158.39 million-$0.40$0.91-143.96%
2017-03-312017-05-02$139.47 million-$1.06$1.50-170.67%
2016-12-312017-02-14$151.59 million$1.85$1.89-2.12%
2016-09-302016-11-03$143.78 million$1.78$1.5018.67%
2016-06-302016-08-09$127.42 million$1.45$1.2020.83%
2016-03-312016-05-03$109.3 million$0.94$1.11-15.32%
2015-12-312016-02-17$108.74 million$1.12$1.16-3.45%
2015-09-302015-11-03$96.15 million$1.02$1.21-15.7%
2015-06-302015-07-23$123.88 million$1.12$1.13-0.89%
2015-03-312015-05-05$89.51 million$1.17$0.8832.95%
2014-12-312015-02-09$53.25 million$4.67$0.301456.67%
2014-09-302014-10-30$25.49 million$0.06-$0.08175%
2014-06-302014-07-29$24.8 million-$0.07-$0.0922.22%
2014-03-312014-04-24$20.84 million-$0.33-$0.06-450%
2013-12-312014-02-06$21.71 million-$0.17-$0.10-70%
2013-09-302013-10-23$21.62 million-$0.01-$0.1291.67%
2013-06-302013-08-01$19.65 million-$0.09-$0.1643.75%
2013-03-312013-04-23$17.88 million-$0.19-$0.219.52%
2012-12-312013-03-01$21.14 million-$0.17-$0.06-183.33%
2012-09-302012-11-01$17.74 million-$0.19-$0.2626.92%
2012-06-302012-07-26$31.01 million$0.14-$0.31145.16%
2012-03-312012-05-01$15.48 million-$0.58-$0.637.94%
2011-12-312012-03-05$14.91 million-$0.87-$1.1121.62%
2011-09-302011-11-04$17.56 million-$0.70-$1.0030%
2011-06-302011-07-26$15.4 million-$0.92-$1.0512.38%
2011-03-312011-05-03$13.39 million-$1.05-$1.02-2.94%
2010-12-312011-02-25$17.22 million-$0.83-$1.0420.19%
2010-09-302010-10-28$16.89 million-$0.81-$1.1026.36%
2010-06-302010-07-28$18.83 million-$1.01-$0.96-5.21%
2010-03-312010-04-27$13.31 million-$1.15-$0.85-35.29%
2009-12-312010-03-01$13.15 million-$1.07-$1.080.93%
2009-09-302009-10-29$3.02 million-$1.29-$1.4712.24%
2009-06-302009-07-29$55000-$1.55-$1.550%
2009-03-312009-04-30$956000-$1.55-$1.30-19.23%
2008-12-312009-02-27$580000-$1.28-$1.4511.72%
2008-09-302008-11-03$260000-$1.39-$1.14-21.93%
2008-06-302008-07-29$486000-$1.00-$0.65-53.85%
2008-03-312008-04-25$612000-$0.55-$0.619.84%
2007-12-312008-02-21$391000-$0.57-$0.49-16.33%
2007-09-302007-10-25$503000-$0.42-$0.444.55%
2007-06-302007-07-25$746000-$0.46-$0.6023.33%
2007-03-312007-04-25$912000-$0.72-$0.58-24.14%
2006-12-312007-01-24-$0.60-$0.50-20%
2006-09-302006-11-20$350000-$0.78-$0.53-47.17%
2006-06-302006-07-20$945000-$0.57-$0.52-9.62%
2006-03-312006-04-20$714000-$0.50-$0.36-38.89%
2005-12-312006-01-19$664000-$0.43-$0.36-19.44%
2005-09-302005-11-16$407000-$0.36-$0.35-2.86%
2005-06-302005-07-19$403000-$0.38-$0.4413.64%
2005-03-312005-04-19$613000-$0.42-$0.420%
2004-12-312005-01-18$1.02 million-$0.32-$0.345.88%
2004-09-302004-11-10$884000-$0.28-$0.26-7.69%
2004-06-302004-07-18$1.47 million-$0.10
2004-03-312004-04-16$766000-$0.07
2003-12-312004-01-16$632000-$0.12
2003-09-302003-11-09$778000$0.15
2003-06-302003-07-18$1.43 million$0.10
2003-03-312003-05-13$1.01 million-$0.10
2002-12-312002-12-31$1.56 million-$0.05
2002-09-302002-09-30$1.03 million-$0.36
2002-06-302002-06-30$1.14 million-$0.02
2002-03-312002-03-31$2.05 million$0.06
2001-12-312001-12-31$1.5 million$0.06
2001-09-302001-09-30$1.74 million$0.02
2001-06-302001-06-30$1.47 million$0.11
2001-03-312001-03-31$1.21 million$0.08
2000-12-312000-12-31$1.55 million-$0.08
2000-06-302000-06-30$1 million-$0.09
2000-03-312000-03-31$701000-$0.15
1999-12-311999-12-31-$0.21
1999-06-301999-06-30-$0.35
1999-03-311999-03-31-$0.12
1998-12-311998-12-31-$0.39
1997-09-301997-11-07-$0.30-$0.04-650%
1997-06-301997-07-16-$0.08$0.04-300%
1997-03-311997-04-15-$0.16-$0.08-100%
1996-12-311997-01-21$0.63$0.3485.29%
1996-09-301996-11-06-$0.37-$0.31-19.35%
1996-06-301996-07-16-$0.42-$0.24-75%
1996-03-311996-04-17-$0.36-$0.22-63.64%
1995-12-311996-01-17-$0.28$0.33-184.85%
1994-09-301994-11-04-$0.35-$0.04-775%
1994-06-301994-07-18$0.13-$0.04425%
1994-03-311994-04-13$0.05$0.00
1993-12-311994-01-14-$0.05$0.01-600%
1993-09-301993-11-05-$0.12-$0.03-300%
1993-06-301993-07-19-$0.24$0.01-2500%
1993-03-311993-04-20$0.00-$0.04100%
1992-12-311993-01-16$0.01-$0.04125%

AMAG Pharmaceuticals, Inc (AMAG) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

AMAG Pharmaceuticals, Inc (AMAG) Chart:

AMAG Pharmaceuticals, Inc (AMAG) News:

Below you will find a list of latest news for AMAG Pharmaceuticals, Inc (AMAG) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

AMAG Pharmaceuticals, Inc (AMAG) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2021-05-2120CALL 234.06FALSE00
2021-05-2130CALL 265.31FALSE00
2021-05-2140CALL 212.33FALSE00
2021-05-2150CALL 176.05FALSE00
2021-05-2160CALL 166.33FALSE00
2021-05-2170CALL 141.64FALSE00
2021-05-2186.79CALL1 0120.98FALSE6.790
2021-05-2190CALL 103.08FALSE00
2021-05-21100CALL 87.14FALSE00
2021-05-21110CALL 67.68FALSE00
2021-05-21121.55CALL9 1159.64FALSE-1.10
2021-05-21130.75CALL5 063.21FALSE-0.150
2021-05-21140.1CALL25 00FALSE-0.250
2021-05-21150.05CALL1 00FALSE-0.350
2021-05-21160.05CALL5 770FALSE00
2021-05-21170CALL 0FALSE00
2021-05-21180.05CALL5 00FALSE00
2021-05-2120PUT 0TRUE00
2021-05-2130PUT 0TRUE00
2021-05-2140PUT 0TRUE00
2021-05-2150PUT 0TRUE00
2021-05-2160PUT 0TRUE00
2021-05-2170PUT 0TRUE00
2021-05-2180PUT 0TRUE00
2021-05-2190.05PUT9 90TRUE0.050
2021-05-21100.05PUT9 90TRUE0.050
2021-05-21110.05PUT4 00TRUE-0.30
2021-05-21120.05PUT30 00TRUE00
2021-05-21130.05PUT241 00TRUE0.150
2021-05-21140.35PUT85 08.32TRUE0.550
2021-05-21151.5PUT1 94.76TRUE-0.5-0.25
2021-05-21160PUT 34.37TRUE00
2021-05-21170PUT 39.38TRUE00
2021-05-21180PUT 45.09TRUE00
2022-01-2134.85CALL3 00FALSE0.350
2022-01-2150CALL 32.13FALSE00
2022-01-2187.1CALL1 033.08FALSE1.30
2022-01-21103.7CALL20 3219.38FALSE-1.640
2022-01-21122CALL2 040.4FALSE0.50
2022-01-21150.05CALL31 05.33FALSE00
2022-01-21170.05CALL11 011.45FALSE00
2022-01-21200.05CALL10 110FALSE-0.050
2022-01-21220.05CALL13 1200FALSE-0.050
2022-01-21250.1CALL4 40FALSE0.10
2022-01-2130.05PUT1 00TRUE00
2022-01-2150.05PUT3 520TRUE00
2022-01-2180.05PUT1 00TRUE00
2022-01-21100.05PUT10 00TRUE-0.30
2022-01-21120.05PUT5 00TRUE00
2022-01-21152PUT4 00TRUE-0.20
2022-01-21170PUT 24.97TRUE00
2022-01-21200PUT 36.04TRUE00
2022-01-21220PUT 28.52TRUE00
2022-01-212515.8PUT 150.19TRUE00

AMAG Pharmaceuticals, Inc (AMAG) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000066/0000792977-20-000066-index.htm
2019-09-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/792977/000000000019013610/0000000000-19-013610-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000009375120000337/0000093751-20-000337-index.htm
2020-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000076999320000081/0000769993-20-000081-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000043/0000792977-19-000043-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000044/0000792977-19-000044-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000045/0000792977-19-000045-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000046/0000792977-19-000046-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000047/0000792977-19-000047-index.htm
2019-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000048/0000792977-19-000048-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000050/0000792977-19-000050-index.htm
2019-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000052/0000792977-19-000052-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000056/0000792977-19-000056-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000065/0000792977-19-000065-index.htm
2019-04-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000068/0000792977-19-000068-index.htm
2019-04-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000070/0000792977-19-000070-index.htm
2019-04-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000072/0000792977-19-000072-index.htm
2019-04-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000074/0000792977-19-000074-index.htm
2019-04-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000075/0000792977-19-000075-index.htm
2019-04-15DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000077/0000792977-19-000077-index.htm
2019-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000079/0000792977-19-000079-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000081/0000792977-19-000081-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/792977/000079297719000084/0000792977-19-000084-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000087/0000792977-19-000087-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000088/0000792977-19-000088-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000091/0000792977-19-000091-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000102/0000792977-19-000102-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000103/0000792977-19-000103-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000104/0000792977-19-000104-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000105/0000792977-19-000105-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000106/0000792977-19-000106-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000107/0000792977-19-000107-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000108/0000792977-19-000108-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000109/0000792977-19-000109-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000111/0000792977-19-000111-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000113/0000792977-19-000113-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000116/0000792977-19-000116-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000119/0000792977-19-000119-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/792977/000079297719000121/0000792977-19-000121-index.htm
2019-09-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000124/0000792977-19-000124-index.htm
2019-10-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000127/0000792977-19-000127-index.htm
2019-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297719000128/0000792977-19-000128-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000131/0000792977-19-000131-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000134/0000792977-19-000134-index.htm
2019-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/792977/000079297719000137/0000792977-19-000137-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297719000140/0000792977-19-000140-index.htm
2020-01-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000004/0000792977-20-000004-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000009/0000792977-20-000009-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000016/0000792977-20-000016-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000017/0000792977-20-000017-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000018/0000792977-20-000018-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000019/0000792977-20-000019-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000020/0000792977-20-000020-index.htm
2020-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000021/0000792977-20-000021-index.htm
2020-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/792977/000079297720000027/0000792977-20-000027-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000030/0000792977-20-000030-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000031/0000792977-20-000031-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000033/0000792977-20-000033-index.htm
2020-04-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000036/0000792977-20-000036-index.htm
2020-04-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000037/0000792977-20-000037-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000042/0000792977-20-000042-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/792977/000079297720000043/0000792977-20-000043-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000045/0000792977-20-000045-index.htm
2020-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000048/0000792977-20-000048-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000056/0000792977-20-000056-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000057/0000792977-20-000057-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000058/0000792977-20-000058-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000059/0000792977-20-000059-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000060/0000792977-20-000060-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000061/0000792977-20-000061-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000062/0000792977-20-000062-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000064/0000792977-20-000064-index.htm
2020-06-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000066/0000792977-20-000066-index.htm
2020-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000068/0000792977-20-000068-index.htm
2020-07-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000070/0000792977-20-000070-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000072/0000792977-20-000072-index.htm
2020-08-11NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/792977/000079297720000075/0000792977-20-000075-index.htm
2020-08-1710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/792977/000079297720000080/0000792977-20-000080-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000081/0000792977-20-000081-index.htm
2020-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000079297720000083/0000792977-20-000083-index.htm
2020-09-1510-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/792977/000079297720000090/0000792977-20-000090-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000079297720000092/0000792977-20-000092-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/792977/000079297720000094/0000792977-20-000094-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000083423720001671/0000834237-20-001671-index.htm
2019-08-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/792977/000090266419003418/0000902664-19-003418-index.htm
2019-08-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000090266419003419/0000902664-19-003419-index.htm
2019-09-04PREC14APreliminary proxy statements, contested solicitationshttps://www.sec.gov/Archives/edgar/data/792977/000090266419003607/0000902664-19-003607-index.htm
2019-09-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/792977/000090266419003608/0000902664-19-003608-index.htm
2019-09-04DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000090266419003609/0000902664-19-003609-index.htm
2019-09-16DEFC14ADefinitive proxy statement, contested solicitationshttps://www.sec.gov/Archives/edgar/data/792977/000090266419003717/0000902664-19-003717-index.htm
2019-09-16DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000090266419003718/0000902664-19-003718-index.htm
2019-09-16DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000090266419003736/0000902664-19-003736-index.htm
2019-09-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000090266419003738/0000902664-19-003738-index.htm
2019-09-26DFAN14AAdditional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000090266419003829/0000902664-19-003829-index.htm
2019-09-26DFRN14ARevised definitive proxy statement filed by non-managementhttps://www.sec.gov/Archives/edgar/data/792977/000090266419003831/0000902664-19-003831-index.htm
2019-10-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/792977/000090266419003959/0000902664-19-003959-index.htm
2019-10-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000090266419003962/0000902664-19-003962-index.htm
2020-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000090266420002288/0000902664-20-002288-index.htm
2019-05-20SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000091957419003784/0000919574-19-003784-index.htm
2019-06-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000091957419004320/0000919574-19-004320-index.htm
2019-06-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000091957419004322/0000919574-19-004322-index.htm
2019-06-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000091957419004988/0000919574-19-004988-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm
2020-01-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000091957420001490/0000919574-20-001490-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000091957420002015/0000919574-20-002015-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000091957420002488/0000919574-20-002488-index.htm
2020-10-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000091957420006223/0000919574-20-006223-index.htm
2020-10-01SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/792977/000095014220002337/0000950142-20-002337-index.htm
2020-10-13SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/792977/000095014220002399/0000950142-20-002399-index.htm
2020-10-26SC TO-T/ATender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/792977/000095014220002432/0000950142-20-002432-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000103738920000005/0001037389-20-000005-index.htm
2020-04-15PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/792977/000104746920002313/0001047469-20-002313-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/792977/000104746920002674/0001047469-20-002674-index.htm
2019-04-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465919020170/0001104659-19-020170-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465919020171/0001104659-19-020171-index.htm
2019-05-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/792977/000110465919030015/0001104659-19-030015-index.htm
2019-09-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000110465919048745/0001104659-19-048745-index.htm
2019-09-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000110465919048805/0001104659-19-048805-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000110465920018256/0001104659-20-018256-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000110465920028904/0001104659-20-028904-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920029288/0001104659-20-029288-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920029290/0001104659-20-029290-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920029291/0001104659-20-029291-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920029292/0001104659-20-029292-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920029295/0001104659-20-029295-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920029296/0001104659-20-029296-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920032482/0001104659-20-032482-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920032483/0001104659-20-032483-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920032485/0001104659-20-032485-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000110465920032487/0001104659-20-032487-index.htm
2020-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000110465920047191/0001104659-20-047191-index.htm
2020-09-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/792977/000110465920105287/0001104659-20-105287-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000110465920111126/0001104659-20-111126-index.htm
2020-10-01SC14D9CWritten communication relating to third party tender offerhttps://www.sec.gov/Archives/edgar/data/792977/000110465920111160/0001104659-20-111160-index.htm
2020-10-01SC14D9CWritten communication relating to third party tender offerhttps://www.sec.gov/Archives/edgar/data/792977/000110465920111163/0001104659-20-111163-index.htm
2020-10-13SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/792977/000110465920114090/0001104659-20-114090-index.htm
2020-10-13SC14D9CWritten communication relating to third party tender offerhttps://www.sec.gov/Archives/edgar/data/792977/000110465920114549/0001104659-20-114549-index.htm
2020-10-15SC 14D9Solicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/792977/000110465920115117/0001104659-20-115117-index.htm
2020-10-26SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/792977/000110465920117995/0001104659-20-117995-index.htm
2020-11-06SC 14D9/ASolicitation, recommendation statementshttps://www.sec.gov/Archives/edgar/data/792977/000110465920122184/0001104659-20-122184-index.htm
2019-04-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000114420419018629/0001144204-19-018629-index.htm
2020-10-15SC TO-TTender offer statement by Third Partyhttps://www.sec.gov/Archives/edgar/data/792977/000119312520269800/0001193125-20-269800-index.htm
2019-09-10PREC14APreliminary proxy statements, contested solicitationshttps://www.sec.gov/Archives/edgar/data/792977/000121390019017568/0001213900-19-017568-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000121390019017826/0001213900-19-017826-index.htm
2019-09-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000121390019017828/0001213900-19-017828-index.htm
2019-09-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/792977/000121390019018069/0001213900-19-018069-index.htm
2019-09-16PRER14APreliminary Proxy Soliciting materialshttps://www.sec.gov/Archives/edgar/data/792977/000121390019018070/0001213900-19-018070-index.htm
2019-09-20DEFC14ADefinitive proxy statement, contested solicitationshttps://www.sec.gov/Archives/edgar/data/792977/000121390019018487/0001213900-19-018487-index.htm
2019-09-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000121390019018617/0001213900-19-018617-index.htm
2019-10-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000121390019019736/0001213900-19-019736-index.htm
2019-10-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/792977/000121390019019941/0001213900-19-019941-index.htm
2019-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/792977/000121390019019951/0001213900-19-019951-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000130692320000005/0001306923-20-000005-index.htm
2019-07-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000165495419008570/0001654954-19-008570-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm
2019-09-20SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/792977/000165495419010958/0001654954-19-010958-index.htm
2019-10-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/792977/000165495419011730/0001654954-19-011730-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/792977/000165495420010821/0001654954-20-010821-index.htm
2020-05-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/792977/999999999720002556/9999999997-20-002556-index.htm
2020-05-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/792977/999999999720002557/9999999997-20-002557-index.htm
2020-05-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/792977/999999999720002558/9999999997-20-002558-index.htm
2020-05-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/792977/999999999720002559/9999999997-20-002559-index.htm

AMAG Pharmaceuticals, Inc (AMAG) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AMAG Pharmaceuticals, Inc (AMAG). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 229%
Institutional Ownership: 10108%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-01Capital Management LP Camber10% Share HolderSell4,390,000.0013.5759,586,787.000.00https://www.sec.gov/Archives/edgar/data/792977/000165495420010821/0001654954-20-010821-index.htm
2020-06-02DAVID EDWARD JOHNSONDirectorBuy10,269.0014,676.00https://www.sec.gov/Archives/edgar/data/792977/000090266420002288/0000902664-20-002288-index.htm
2020-06-02PAUL R. FONTEYNEDirectorBuy10,269.0014,676.00https://www.sec.gov/Archives/edgar/data/792977/000079297720000058/0000792977-20-000058-index.htm
2019-06-25ARMISTICE CAPITAL, LLC10% Share HolderBuy25,000.008.85221,250.00150,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2019-06-25ARMISTICE CAPITAL, LLC10% Share HolderBuy30,000.008.86265,800.00180,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2020-06-02Anne M. PhillipsDirectorBuy10,269.0018,949.00https://www.sec.gov/Archives/edgar/data/792977/000079297720000062/0000792977-20-000062-index.htm
2020-06-02Kathrine O'BrienDirectorBuy10,269.0018,949.00https://www.sec.gov/Archives/edgar/data/792977/000079297720000057/0000792977-20-000057-index.htm
2019-06-27ARMISTICE CAPITAL, LLC10% Share HolderBuy20,000.009.47189,400.00200,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2019-08-07ARMISTICE CAPITAL, LLC10% Share HolderBuy40,000.007.43297,200.00240,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004988/0000919574-19-004988-index.htm
2019-05-16JAMES R SULATDirectorBuy8,116.0024,821.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000106/0000792977-19-000106-index.htm
2019-05-16Barbara DeptulaDirectorBuy8,116.0026,354.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000109/0000792977-19-000109-index.htm
2019-05-16John A. FallonDirectorBuy8,116.0027,093.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000104/0000792977-19-000104-index.htm
2020-01-24ARMISTICE CAPITAL, LLC10% Share HolderBuy40,000.009.72388,800.00280,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm
2020-03-10Kelly SchickChief Human Resources OfficerBuy13,000.0028,234.00https://www.sec.gov/Archives/edgar/data/792977/000110465920032485/0001104659-20-032485-index.htm
2020-01-27ARMISTICE CAPITAL, LLC10% Share HolderBuy8,000.009.4175,280.00288,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm
2019-05-16ROBERT J PEREZDirectorBuy8,116.0029,229.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000107/0000792977-19-000107-index.htm
2020-02-25ARMISTICE CAPITAL, LLC10% Share HolderBuy24,000.008.29198,960.00312,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420002015/0000919574-20-002015-index.htm
2019-05-16GINO SANTINIDirectorBuy8,116.0031,204.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000108/0000792977-19-000108-index.htm
2020-02-25ARMISTICE CAPITAL, LLC10% Share HolderBuy12,000.008.2999,480.00324,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420002015/0000919574-20-002015-index.htm
2019-05-16DAVEY SCOONDirectorBuy8,116.0033,629.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000102/0000792977-19-000102-index.htm
2020-03-16ARMISTICE CAPITAL, LLC10% Share HolderBuy24,000.004.87116,880.00348,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420002488/0000919574-20-002488-index.htm
2020-06-02JAMES R SULATDirectorBuy10,269.0035,090.00https://www.sec.gov/Archives/edgar/data/792977/000079297720000059/0000792977-20-000059-index.htm
2019-06-25ARMISTICE CAPITAL, LLC10% Share HolderBuy0.003,636,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2019-06-25ARMISTICE CAPITAL, LLC10% Share HolderBuy259,016.008.592,224,947.443,636,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2020-06-02John A. FallonDirectorBuy10,269.0037,362.00https://www.sec.gov/Archives/edgar/data/792977/000079297720000060/0000792977-20-000060-index.htm
2019-06-26ARMISTICE CAPITAL, LLC10% Share HolderBuy0.003,756,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2019-06-26ARMISTICE CAPITAL, LLC10% Share HolderBuy120,000.009.131,095,600.003,756,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2019-06-27ARMISTICE CAPITAL, LLC10% Share HolderBuy0.003,800,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2019-06-27ARMISTICE CAPITAL, LLC10% Share HolderBuy44,000.009.52418,880.003,800,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004324/0000919574-19-004324-index.htm
2020-01-09ARMISTICE CAPITAL, LLC10% Share HolderSell0.004,047,534.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm
2020-01-09ARMISTICE CAPITAL, LLC10% Share HolderSell12,466.0012.43154,952.384,047,534.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm
2019-08-07ARMISTICE CAPITAL, LLC10% Share HolderBuy0.004,060,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004988/0000919574-19-004988-index.htm
2019-08-07ARMISTICE CAPITAL, LLC10% Share HolderBuy260,000.007.321,903,200.004,060,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957419004988/0000919574-19-004988-index.htm
2020-01-09ARMISTICE CAPITAL, LLC10% Share HolderBuy0.004,060,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm
2020-01-09ARMISTICE CAPITAL, LLC10% Share HolderBuy12,466.0012.33153,705.784,060,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm
2020-01-10ARMISTICE CAPITAL, LLC10% Share HolderBuy0.004,078,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm
2020-01-10ARMISTICE CAPITAL, LLC10% Share HolderBuy18,000.0011.64209,520.004,078,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000323/0000919574-20-000323-index.htm
2020-01-24ARMISTICE CAPITAL, LLC10% Share HolderBuy0.004,112,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm
2020-01-24ARMISTICE CAPITAL, LLC10% Share HolderBuy34,000.009.58325,720.004,112,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm
2020-01-27ARMISTICE CAPITAL, LLC10% Share HolderBuy0.004,120,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm
2020-01-27ARMISTICE CAPITAL, LLC10% Share HolderBuy8,000.009.4375,440.004,120,000.00https://www.sec.gov/Archives/edgar/data/792977/000091957420000618/0000919574-20-000618-index.htm
2020-06-02GINO SANTINIDirectorBuy10,269.0041,473.00https://www.sec.gov/Archives/edgar/data/792977/000079297720000061/0000792977-20-000061-index.htm
2019-08-07Capital Management LP Camber10% Share HolderBuy301,000.007.792,343,495.704,306,000.00https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm
2019-08-07Capital Management LP Camber10% Share HolderBuy50,000.007.74387,000.004,356,000.00https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm
2019-08-07Capital Management LP Camber10% Share HolderBuy4,000.007.5830,300.004,360,000.00https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm
2019-08-09Capital Management LP Camber10% Share HolderBuy26,600.008.94237,790.704,386,600.00https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm
2020-06-02DAVEY SCOONDirectorBuy10,269.0043,898.00https://www.sec.gov/Archives/edgar/data/792977/000079297720000056/0000792977-20-000056-index.htm
2019-08-09Capital Management LP Camber10% Share HolderBuy3,400.009.1831,205.544,390,000.00https://www.sec.gov/Archives/edgar/data/792977/000165495419009162/0001654954-19-009162-index.htm
2019-10-08DAVID EDWARD JOHNSONDirectorBuy4,407.004,407.00https://www.sec.gov/Archives/edgar/data/792977/000090266419003962/0000902664-19-003962-index.htm
2019-10-08PAUL R. FONTEYNEDirectorBuy4,407.004,407.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000128/0000792977-19-000128-index.htm
2019-05-09WILLIAM K HEIDENPresident & CEOBuy10,000.0010.70107,000.00490,056.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000088/0000792977-19-000088-index.htm
2019-04-10Anne M. PhillipsDirectorBuy564.00564.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000075/0000792977-19-000075-index.htm
2019-04-10Kathrine O'BrienDirectorBuy564.00564.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000070/0000792977-19-000070-index.htm
2019-04-04Anthony CascianoChief Commercial OfficerBuy15,000.0060,852.00https://www.sec.gov/Archives/edgar/data/792977/000110465919020171/0001104659-19-020171-index.htm
2019-05-09Elizabeth Scott BolgianoChief Human Resources OfficerBuy5,000.0010.9354,650.0074,847.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000087/0000792977-19-000087-index.htm
2020-03-10Anthony CascianoChief Commercial OfficerBuy25,000.0078,209.00https://www.sec.gov/Archives/edgar/data/792977/000110465920032482/0001104659-20-032482-index.htm
2019-03-07Joseph VittiglioEVP, General CounselSell1,425.0014.0119,964.2578,955.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000052/0000792977-19-000052-index.htm
2019-05-28Julie KropChief Medical OfficerBuy10,000.009.9199,100.0081,399.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000113/0000792977-19-000113-index.htm
2019-05-16Anne M. PhillipsDirectorBuy8,116.008,680.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000105/0000792977-19-000105-index.htm
2019-05-16Kathrine O'BrienDirectorBuy8,116.008,680.00https://www.sec.gov/Archives/edgar/data/792977/000079297719000103/0000792977-19-000103-index.htm
2020-03-10Joseph VittiglioCBO, General CounselBuy25,000.0092,244.00https://www.sec.gov/Archives/edgar/data/792977/000110465920032483/0001104659-20-032483-index.htm
2020-03-10Edward H MylesCOO & CFOBuy30,000.0098,659.00https://www.sec.gov/Archives/edgar/data/792977/000110465920032487/0001104659-20-032487-index.htm